NO129042B - - Google Patents
Download PDFInfo
- Publication number
- NO129042B NO129042B NO294470A NO294470A NO129042B NO 129042 B NO129042 B NO 129042B NO 294470 A NO294470 A NO 294470A NO 294470 A NO294470 A NO 294470A NO 129042 B NO129042 B NO 129042B
- Authority
- NO
- Norway
- Prior art keywords
- compound
- general formula
- defined above
- yloxy
- formula
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 23
- 150000001412 amines Chemical class 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 125000000468 ketone group Chemical group 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 28
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 239000002904 solvent Substances 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 4
- 241000282472 Canis lupus familiaris Species 0.000 description 4
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 4
- 229940039009 isoproterenol Drugs 0.000 description 4
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000003042 antagnostic effect Effects 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- WQDUMFSSJAZKTM-UHFFFAOYSA-N sodium methoxide Substances [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- SUNMBRGCANLOEG-UHFFFAOYSA-N 1,3-dichloroacetone Chemical compound ClCC(=O)CCl SUNMBRGCANLOEG-UHFFFAOYSA-N 0.000 description 2
- BNRANURXPKRRKP-UHFFFAOYSA-N 1-[tert-butyl-[(4-methylphenyl)methyl]amino]-3-(1H-indol-4-yloxy)propan-2-ol Chemical compound Cc1ccc(CN(CC(O)COc2cccc3[nH]ccc23)C(C)(C)C)cc1 BNRANURXPKRRKP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229960003712 propranolol Drugs 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QWXUJPJVNKCDKJ-UHFFFAOYSA-N 1-(tert-butylamino)-3-chloropropan-2-ol;hydrochloride Chemical compound Cl.CC(C)(C)NCC(O)CCl QWXUJPJVNKCDKJ-UHFFFAOYSA-N 0.000 description 1
- -1 3-amino-2-hydroxy-propoxy group Chemical group 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010067598 Neurogenic hypertension Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000002959 anti-hypotensive effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 102000012740 beta Adrenergic Receptors Human genes 0.000 description 1
- 108010079452 beta Adrenergic Receptors Proteins 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- NBTOZLQBSIZIKS-UHFFFAOYSA-N methoxide Chemical compound [O-]C NBTOZLQBSIZIKS-UHFFFAOYSA-N 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M sodium bicarbonate Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2027869 | 1969-07-30 | ||
| IT2019370 | 1970-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO129042B true NO129042B (de) | 1974-02-18 |
Family
ID=26327437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO294470A NO129042B (de) | 1969-07-30 | 1970-07-29 |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS5010591B1 (de) |
| AT (1) | AT303700B (de) |
| BE (1) | BE753917A (de) |
| CH (1) | CH539017A (de) |
| CS (1) | CS163218B2 (de) |
| DE (1) | DE2037319C3 (de) |
| ES (1) | ES382297A1 (de) |
| FR (1) | FR2059580B1 (de) |
| GB (1) | GB1263035A (de) |
| IE (1) | IE34394B1 (de) |
| NL (1) | NL7011244A (de) |
| NO (1) | NO129042B (de) |
| SE (1) | SE368820B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1436860A (en) * | 1972-12-18 | 1976-05-26 | Syntex Inc | 5,8-dihydro-5,8-methanonaphthalene cardiovascular agents |
-
1970
- 1970-07-17 IE IE93470A patent/IE34394B1/xx unknown
- 1970-07-22 GB GB3555070A patent/GB1263035A/en not_active Expired
- 1970-07-24 BE BE753917D patent/BE753917A/xx unknown
- 1970-07-27 AT AT685570A patent/AT303700B/de not_active IP Right Cessation
- 1970-07-28 DE DE19702037319 patent/DE2037319C3/de not_active Expired
- 1970-07-29 SE SE1040070A patent/SE368820B/xx unknown
- 1970-07-29 NO NO294470A patent/NO129042B/no unknown
- 1970-07-29 ES ES382297A patent/ES382297A1/es not_active Expired
- 1970-07-29 NL NL7011244A patent/NL7011244A/xx unknown
- 1970-07-30 JP JP6646970A patent/JPS5010591B1/ja active Pending
- 1970-07-30 FR FR7028201A patent/FR2059580B1/fr not_active Expired
- 1970-07-30 CH CH1153170A patent/CH539017A/de not_active IP Right Cessation
- 1970-07-30 CS CS534870A patent/CS163218B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5010591B1 (de) | 1975-04-22 |
| BE753917A (fr) | 1971-01-25 |
| NL7011244A (de) | 1971-02-02 |
| DE2037319A1 (de) | 1971-02-11 |
| AT303700B (de) | 1972-12-11 |
| DE2037319B2 (de) | 1973-04-26 |
| CH539017A (de) | 1973-07-15 |
| FR2059580B1 (de) | 1973-12-21 |
| DE2037319C3 (de) | 1973-11-22 |
| ES382297A1 (es) | 1973-04-16 |
| CS163218B2 (de) | 1975-08-29 |
| GB1263035A (en) | 1972-02-09 |
| IE34394B1 (en) | 1975-04-30 |
| IE34394L (en) | 1971-01-30 |
| FR2059580A1 (de) | 1971-06-04 |
| SE368820B (de) | 1974-07-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5495047A (en) | Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy | |
| JP3120873B2 (ja) | ピリジン誘導体 | |
| US4243807A (en) | 4-Phenoxymethyl-piperidines | |
| NO141487B (no) | Traadloest informasjonstransmisjonssystem | |
| Turner et al. | Studies on imidazole compounds. I. 4-Methylimidazole and related compounds | |
| US4680296A (en) | Piperidine derivatives and pharmaceutical compositions containing them | |
| NO118710B (de) | ||
| CS201040B2 (en) | Method of producing etherified hydroxy-benzo-diheterocyclic compounds | |
| NO162176B (no) | Middel for bekjempelse av plantesykdommer og anvendelse derav. | |
| NZ195357A (en) | Quinoline derivatives and pharmaceutical compositions | |
| JPH0684370B2 (ja) | ムスカリンレセプター拮抗薬 | |
| NO164349B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-(piperidinyl-alkyl)-karboksamider og deres salter. | |
| US3705907A (en) | 4-(2-hydroxy)-3-aminopropoxy)-indole derivatives | |
| US4110536A (en) | Derivatives of 5-(indol-3-yl)hydantoin | |
| NO820047L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreamider | |
| Nagarathnam | A facile synthesis of 3‐substituted indoles | |
| US4650811A (en) | Ethenylphenol-indoles having antiarythmic utility | |
| SU1042612A3 (ru) | Способ получени производных индола или их солей | |
| EP0041757B1 (de) | Äthylendiaminderivate, ihre Herstellung, sie enthaltende pharmazeutische Zusammensetzungen sowie Zwischenprodukte zu ihrer Herstellung | |
| US4442102A (en) | 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same | |
| NO129042B (de) | ||
| GB2142021A (en) | 1 4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them | |
| US4853408A (en) | 4-phenylpropyl-indoles having antiarythmic activity | |
| NO126914B (de) | ||
| SU670216A3 (ru) | Способ получени производных оксима или их солей |